Fund profile

K50 Ventures

New York, United States

Leading

About

K50 Ventures, established in 2017 and headquartered in New York, is a venture capital firm dedicated to funding purpose-driven companies at the pre-seed and seed stages. The firm focuses on startups that aim to improve access and affordability in health, finance, and work for the global working class. Notable investments include Mammoth Biosciences, a pioneer in CRISPR technology; Groww, a mobile investing platform in India; and Midi Health, providing specialized healthcare for women over 40. K50 Ventures supports companies that democratize access to financial services, improve healthcare delivery, and empower small businesses and independent workers. Led by founders Ryan Bloomer and Adriel Bercow, K50 Ventures is committed to being the first institutional check and a long-term partner to mission-driven entrepreneurs. They seek founders with a clear vision for creating significant social impact and a solid strategy for execution.

Details

Highlights

$704.5k

Historical average check

$63M

Historical max check

December 2024

Last investment date

174

Investments

Healthtech & Wellness

Software & Apps

Real Estate & Proptech

E-commerce & Retail

Fintech & Financial services

Hardware. Robotics & IoT

Other

Funds that also invest in AI & Deep Tech